Japanese court rejects Viatris' bid to block Sawai Amitiza generic
An Osaka District Court ruling handed Japanese generics maker Sawai Pharmaceutical a win against Viatris’ Japan unit, holding that a later patent extension for a new dose can’t be used to...To view the full article, register now.
Already a subscriber? Click here to view full article